🕵️ Dolby Laboratories, Inc. ($DLB)
SEC insider & ownership activity, last 12 months · CIK 1308547 · every row links its SEC filing
Over the last 12 months insiders sold $17.7M with no open-market buying against it. Yeaman Family Trust sold $10.5M through a 10b5-1 trading plan in 10 lots (Sep–Dec). Dagmar Dolby trimmed 36.6% → 36.0%; Dagmar Dolby, AS (trustee) trimmed 8.9% → 8.0%. No red-flag 8-Ks in the window.
🚨 3 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $17.7M (39 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Yeaman Family Trust | 0 | – | 10 | $10.5M | Dec 17, 2025 |
| John Couling | 0 | – | 12 | $3.8M | Sep 1, 2026 |
| Mark Andrew Sherman | 0 | – | 4 | $1.1M | Dec 17, 2025 |
| Shriram Revankar | 0 | – | 4 | $748K | Aug 14, 2026 |
| Todd Pendleton | 0 | – | 1 | $648K | May 22, 2026 |
| Ryan H. Nicholson | 0 | – | 4 | $360K | Aug 25, 2026 |
| Robert Park | 0 | – | 2 | $277K | May 12, 2026 |
| Tony Prophet | 0 | – | 1 | $224K | Nov 25, 2025 |
| Emily Rollins | 0 | – | 1 | $60K | Apr 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Dagmar Dolby | 36.0% | 13D | Feb 11, 2026 | filing ↗ | |
| David E. Dolby | 35.8% | 13D | Jan 30, 2025 | filing ↗ | |
| David E. Dolby | 35.2% | 13D | Feb 11, 2026 | filing ↗ | |
| Dagmar Dolby, AS (trustee) | 25.2% | 13D | Feb 11, 2026 | filing ↗ | |
| BlackRock, Inc. | 10.0% | 13G | Jun 4, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 8.2% | 13G | Apr 29, 2026 | filing ↗ | |
| Morgan Stanley | 8.2% | 13G | May 11, 2026 | filing ↗ | |
| Dagmar Dolby, AS (trustee) | 8.0% | 13D | Feb 11, 2026 | filing ↗ | |
| Bank of New YORK Mellon Corp | 7.4% | 13G | Apr 28, 2026 | filing ↗ | |
| Eaton Vance Atlanta Capital SMID-Cap Fund | 6.5% | 13G | Feb 11, 2026 | filing ↗ | |
| Atlanta Capital Management Company, LLC | 6.4% | 13G | May 11, 2026 | filing ↗ | |
| BNY Mellon IHC, LLC | 6.2% | 13G | Apr 28, 2026 | filing ↗ | |
| MBC Investments Corp | 6.2% | 13G | Apr 28, 2026 | filing ↗ | |
| Newton Investment Management North America, LLC | 5.4% | 13G | Apr 28, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| John Couling | $468K | Sep 1, 2026 | filing ↗ |
| Ryan H. Nicholson | $77K | Aug 25, 2026 | filing ↗ |
| Shriram Revankar | $188K | Aug 14, 2026 | filing ↗ |
| Ryan H. Nicholson | $84K | Aug 10, 2026 | filing ↗ |
| John Couling | $460K | Aug 3, 2026 | filing ↗ |
| John Couling | $408K | Jul 1, 2026 | filing ↗ |
| John Couling | $426K | Jun 1, 2026 | filing ↗ |
| Todd Pendleton | $648K | May 22, 2026 | filing ↗ |
| Shriram Revankar | $165K | May 15, 2026 | filing ↗ |
| Robert Park | $277K | May 12, 2026 | filing ↗ |
| John Couling | $441K | May 5, 2026 | filing ↗ |
| John Couling | $274K | May 4, 2026 | filing ↗ |
| Emily Rollins | $60K | Apr 1, 2026 | filing ↗ |
| Shriram Revankar | $198K | Feb 17, 2026 | filing ↗ |
| Ryan H. Nicholson | $177K | Feb 13, 2026 | filing ↗ |
| John Couling | $433K | Feb 2, 2026 | filing ↗ |
| Mark Andrew Sherman | $168K | Dec 17, 2025 | filing ↗ |
| Yeaman Family Trust | $454K | Dec 17, 2025 | filing ↗ |
| Yeaman Family Trust | $1.8M | Dec 16, 2025 | filing ↗ |
| Mark Andrew Sherman | $608K | Dec 16, 2025 | filing ↗ |
| John Couling | $500K | Dec 11, 2025 | filing ↗ |
| Yeaman Family Trust | $2.3M | Dec 9, 2025 | filing ↗ |
| Mark Andrew Sherman | $304K | Dec 1, 2025 | filing ↗ |
| Tony Prophet | $224K | Nov 25, 2025 | filing ↗ |
| Yeaman Family Trust | $2.5M | Nov 24, 2025 | filing ↗ |
| Shriram Revankar | $197K | Nov 21, 2025 | filing ↗ |
| John Couling | $408K | Nov 20, 2025 | filing ↗ |
| Yeaman Family Trust U/A DTD 05/14/2009 | $1.7M | Oct 14, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 25, 2026 | filing ↗ |
| Other events (8.01) | Aug 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2026 | filing ↗ |
| Earnings (2.02) | Jul 30, 2026 | filing ↗ |
| Other events (8.01) | Jul 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Other events (8.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Feb 3, 2026 | filing ↗ |
| Earnings (2.02) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Earnings (2.02) | Nov 18, 2025 | filing ↗ |
| Other events (8.01) | Nov 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 18, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 11, 2025 | filing ↗ |